| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-13 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.29 | 3e-13 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.22 | 8e-12 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-11 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.24 | 9e-11 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-10 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.22 | 2e-10 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.21 | 8e-10 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-09 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-09 |